October 14, 2020 – Johnson & Johnson Innovation announced today at the virtual 2020 HLTH conference the awardees for the JLABS @ Washington, DC Children’s, Maternal Health, and Diversity in Innovation QuickFire Challenges, which respectively aimed to catalyze pediatric innovation, improve maternal health in the United States, and support diverse innovators. These challenges embody Johnson & Johnson Innovation’s commitment to catalyzing potential solutions to today’s greatest healthcare challenges.
The awardees will receive funding from a total of $650,000 in grants, access to the Johnson & Johnson Innovation – JLABS ecosystem, and mentorship from experts at the Johnson & Johnson Family of Companies.
The JLABS @ Washington, DC Children’s QuickFire Challenge named AlgometRx, Congruence Medical Solutions, Gabi SmartCare, and LifeSprout as the awardees. The challenge, which was launched in honor of the new JLABS @ Washington, DC opening in 2021, invited innovators with potential solutions to transform care in pediatric oncology, pediatric surgical care, and influenza to apply. Awardees will be granted a total of $150,000 in funding along with mentorship from experts at the Johnson & Johnson Family of Companies. They will also join the JLABS @ Washington, DC community of portfolio companies.
The AlgometRx Nociometer® is a platform technology for the objective assessment of pain type and intensity, enabling the development of a novel application focused on establishing a pediatric Chemotherapy Induced Peripheral Neuropathy (CIPN) assessment tool with the aim to permit early detection and long-term monitoring of a significant morbidity of cancer treatment.
Congruence Medical Solutions
Congruence Medical Solutions, LLC provides device-based drug delivery solutions for applications involving injection of microliter volume doses.
Gabi SmartCare aims to empower researchers, physicians and parents with data driven health assessment to disrupt pediatric healthcare & improve children’s lives.
LifeSprout’s injectable product portfolio is designed with the aim to offer immediate tissue restoration and regeneration that looks and behaves like natural tissue following pediatric oncologic reconstruction.
Together with the Johnson & Johnson Office of the Chief Medical Officer (OCMO) Women’s Health team, the Maternal Health QuickFire Challenge has selected National Birth Equity Collaborative, Pronto International, Memora Health, and Alydia Health as the awardees. The Challenge was designed with the aim to improve pregnancy, birth, and postpartum care for women, making birth safer in the United States and potentially changing the trajectory of health for a lifetime.
National Birth Equity Collaborative
National Birth Equity Collaborative through an innovative partnership with Omaiven Health is improving the maternal health crisis for all, by placing special emphasis on the challenges faced by those most affected - Black mothers and mothers of color. The team's culturally inclusive platform delivers a space for birthing professionals (Doulas, Midwives, etc.) and mothers to connect, boost engagement, and deliver digital-powered care throughout the perinatal period.
PRONTOStat is a uniquely engaging, low-cost, and sustainable simulation and team training package designed to transform the care of mothers and babies by the emergency care teams that have to manage them in maternity care deserts in the United States.
Memora Health has developed a digital health platform that provides new mothers with a 24/7 texting service that responds automatically to patient concerns with clinically validated answers, redefining postpartum care delivery in the United States.
Alydia Health’s Jada uses a gentle vacuum to induce the normal function of the uterus, helping a mother’s body initiate contractions and stop abnormal uterine bleeding and postpartum hemorrhage.
Cura Therapeutics, TEZCAT Laboratories LLC, Theradaptive, and Seaspire, Inc. have been selected as the awardees in the Diversity in Innovation QuickFire Challenge. The Challenge offered an opportunity for multicultural innovators who are Black/ African American, Hispanic/ Latino, and American Indian or Alaska Native to receive funding and mentorship with the aim to help advance their science.
Cura Therapeutics is developing an innovative immunotherapy platform to treat a wide range of solid malignancies and infectious diseases. Their technologies harness cytokines and immune receptors to create multi-functional proteins with potent anti-cancer and anti-viral properties.
TEZCAT Laboratories LLC
TEZCAT Laboratories LLC is an early-stage biotechnology company focused on developing innovative protein-drug conjugates aimed to treat mutant Ras cancers.
Theradaptive aims to redefine regenerative medicine with a platform technology for precise delivery of biologics to enable outcomes that are out of reach for current therapeutics.
Seaspire, Inc. aims to redefine skincare formulations with exceptionally effective ingredients inspired by nature to make the world healthier, safer, and more sustainable.
Johnson & Johnson Innovation – JLABS has developed the QuickFire Challenge platform with the aim to empower and enable potential groundbreaking science and healthcare solutions by encouraging students, entrepreneurs, researchers and start-up companies to tackle some of the world's most challenging problems in healthcare.
About Johnson & Johnson Innovation
Johnson & Johnson Innovation, LLC focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers; Johnson & Johnson Innovation—JLABS; Johnson & Johnson Innovation – JJDC, Inc.; and our business development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. JLABS provides the laboratories, expertise, education, tools and resources needed to help life science startups thrive, all with no strings attached. A Johnson & Johnson Innovation Center for Device Innovation at the Texas Medical Center (CDI @ TMC) has been established to accelerate the development of medical devices. For more information about Johnson & Johnson Innovation, please visit: www.jnjinnovation.com.
About Johnson & Johnson Innovation — JLABS
Johnson & Johnson Innovation – JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators across a broad healthcare spectrum including pharmaceutical, medical device, consumer and health tech sectors to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS, we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS also produces campaigns to seek out the best science called QuickFire Challenges. For more information, visit www.jlabs.jnjinnovation.com or follow @JLABS.